US biosynthesis company delivering 21st-century pharmaceutical manufacturing and innovation, Antheia, today announced it has ...

US drug developer Cytokinetics today announced that Myqorzo (aficamten) is now available for prescription in 5mg, 10mg, 15mg ...

UK pharma major GSK today announced that its adjuvanted recombinant respiratory syncytial virus (RSV) vaccine, Arexvy, has been approved by the European Commission (EC) for use in adults aged 18 years ...

In a significant ruling for pharmaceutical regulation in India, the Delhi High Court has reinstated the Indian government's ...

Advicenne’s shares rose 6% to 1.76 euros this morning, on the news it has obtained both marketing authorization (MA) and ...

Servier, an independent pharma governed by a foundation, has published its financial results for the 2024/25 financial year.

Swedish women’s health specialist Gedea Biotech today announces a planned chief executive (CEO) transition. After close to ...

US biotech Fortitude Biomedicines has emerged from stealth with $13 million in seed funding to develop a hybrid biologics ...

The Centers for Medicare & Medicaid Services (CMS) is seeking public input on ways to strengthen domestic supply chains for ...

Hangzhou, China-based privately-held HealZen Therapeutics has announced a new strategic partnership with an unnamed US ...

Chinese biotech Huahui Health has won conditional approval for Libevitug (libevitug) to treat adults with chronic hepatitis D ...

Chinese cell therapy company NewCure Biotech has raised more than 200 million yuan ($28 million) in a series B round to ...